The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Gilead Sciences to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15

<p class='bwalignc'> <i><b>Webcast Available Through Gilead Corporate Website</b></i> </p>

Monday, November 14, 2011

Gilead Sciences to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 1516:30 EST Monday, November 14, 2011 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Lazard Capital Markets 8th Annual Healthcare Conference in New York. John C. Martin, PhD, Gilead's Chairman and Chief Executive Officer, will provide an overview of the company on Tuesday, November 15 at 1:00 p.m. Eastern Time. To access the live webcast or a replay via the Internet, log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Patrick O?Brien, 650-522-1936 (Investor Relations)